This neoplasm is not reportable.

Name

Juvenile xanthogranuloma (JXG)

ICD-O-3 Morphology

9749/1
Effective 2023 and later

Reportability

This neoplasm is not reportable

Primary Site(s)

C700-C729, C751-C753
This neoplasm is reportable for primary sites C700-C729, C751-C753 only.

Abstractor Notes

This is a new reportable neoplasm for 2023 for primary sites C700-C729, C751-C753 only. If the diagnosis is prior to 1/1/2023, it is not reportable.

JXG is generally confined to the skin, with a predilection for head and neck, upper trunk, and proximal extremities. Ocular involvement can rarely occur, and is usually solitary.

JXG can also occur in the CNS (brain, intradural extramedullary spin, nerve roots, and meninges.) CNS involvement usually occurs in children and young adults.

Diagnostic Confirmation

This histology can be determined by positive histology (including peripheral blood) with or without genetics and/or immunophenotyping. Review the Definitive Diagnostic Methods, Immunophenotyping and Genetics Data sections below, and the instructions in the Hematopoietic Manual for further guidance on assigning Diagnostic confirmation.

Alternate Names

Benign cephalic histiocytosis
Disseminated juvenile xanthogranuloma

Definition

Histology that presents in infants as a single or several cutaneous papulo-nodular lesions. Lesions are general asymptomatic and evolve from raised, pink to dark brown lesion with progressive flattening and can disappear within months or years with scarring or anetodema.

Benign cephalic histiocytosis is a clinical subtype presenting as an asymptomatic papular eruption predominantly in the head and neck of young children with self-healing properties.

In adults, lesions are often large, solitary and persistent and it is important to exclude Erdheim-Chester disease (9749/3)

Definitive Diagnostic Methods

This data item does not apply

Genetics Data

This data item does not apply

Immunophenotyping

This data item does not apply

Corresponding ICD-9 Codes

238.5 Histiocytic and mast cells

Corresponding ICD-10 Codes

D76.3 Other histiocytosis syndromes

Corresponding ICD-10-CM Codes (U.S. only)

D76.3 Other histiocytosis syndromes (effective October 01, 2015)

Signs and Symptoms

Single or multiple cutaneous papulo-nodular lesions

Epidemiology and Mortality

Age: children and young adults, mostly in first year of life
Incidence: 0.5% of all pediatric tumors, male predilection
Survival: excellent prognosis with favorable outcome except when dissiminated

Sources

WHO Classification of Tumours Editorial Board. Hematopoietic Neoplasms [Internet]. Lyon (France): International Agency for Research on Cancer; 2021 [cited 2022/08/22 WHO classification of tumours series, 5th ed.). Available from: https://tumourclassification.iarc.who.int/chapters/63
Section: Section: Histiocytic/Dendritic cell neoplasms

WHO Classification of Tumours Editorial Board. Central nervous system tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2021 [cited 2022/08/22 WHO classification of tumours series, 5th ed.; vol. 6). Available from: https://tumourclassification.iarc.who.int/chapters/45.
Section: Haematolymphoid tumors involving the CNS
Glossary